四环医药于2025年8月29日发布中期业绩,以“医美+医药”双轮驱动为核心战略,实现业务稳健增长。尤其在医美板块,通过产品创新和渠道深耕,销售收入同比增长81.3%至约5.85亿元。渼颜空间作为核心增长引擎,成为国内首家集齐肉毒毒素、少女针、童颜针、玻尿酸、光电设备等全品类的医美公司,市场占有率显著提升。公司在营销与渠道建设上取得显著成果,覆盖全国370多个城市、6800多家医美机构,并与近...
Source Link四环医药于2025年8月29日发布中期业绩,以“医美+医药”双轮驱动为核心战略,实现业务稳健增长。尤其在医美板块,通过产品创新和渠道深耕,销售收入同比增长81.3%至约5.85亿元。渼颜空间作为核心增长引擎,成为国内首家集齐肉毒毒素、少女针、童颜针、玻尿酸、光电设备等全品类的医美公司,市场占有率显著提升。公司在营销与渠道建设上取得显著成果,覆盖全国370多个城市、6800多家医美机构,并与近...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.